Novartis India Limited

NOVARTIND NSE Healthcare Pharmaceuticals
₹2,366.00
-2.56%
Delayed · cached 15 min

Fair value analysis

NOVARTIND
Novartis India Limited
HealthcarePharmaceuticals
₹2,428.20
Close used for this calculation
₹1,024.50Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
46/100
Profitability25/25
Returns5/25
Balance Sheet11/25
Efficiency5/25
Growth15/25
Average
Quality radar
46Prof.25/25Ret.5/25Eff.5/25B.Sht11/25Growth15/25

Consensus fair value

₹1,024.50
Above FV
▼ -57.8% against the close used
Model range ₹375.52 – ₹1,699.65
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹375.52Fair value₹1,024.50Bull₹1,699.65
FairClose
52-week traded range
52W low ₹672.2552W high ₹2,428.20

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Novartis India Limited closed at ₹2,428.20, 137.0% above the consensus fair value of ₹1,024.50 drawn from 10 valuation models.

Financial DNA score 46/100 — Average. P/E of 60.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹375.52
-84.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹547.05
-77.5%
√(22.5 × EPS × BVPS)
EPS=37.74, BVPS=352.42 · outside Graham range (P/E 60.4, P/B 6.9) — asset-light, treat as a rough floor
Graham Formula
₹1,699.65
-30.0%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹1,347.32
-44.5%
EPS × 35.7x (sector P/E)
EPS=37.74, Sector P/E=35.7x
Peter Lynch (PEG)
₹943.50
-61.1%
EPS × Growth% (PEG = 1 is fair)
EPS=37.74, g=25%
EV/EBITDA
₹709.46
-70.8%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=960M
Dividend Discount (DDM)
₹1,376.79
-43.3%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=25.5, r=10%, g=8%
Book Value (P/B)
₹493.39
-79.7%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=352.42, ROE=11.6%, g=6%, r=10%
Reverse DCF
₹2,428.20
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 23% | Historical: 25%
Margin of Safety
₹744.29
-69.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=992.39, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.